Moreover, the observed significantly higher concentrations of these autophagy proteins in CIS-treated Gal-3 KO mice compared to those in CIS-treated Gal-3 wild-type mice suggest that the absence of the Gal-3 gene can enhance autophagy. This evidence concerns the gene LGALS3 and in situ carcinoma.